Achilles Therapeutics
-$0.12 (-0.84%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell ACHL and other stocks, options, and ETFs commission-free!
About ACHL
Achilles Therapeutics plc American Depositary Shares, also called Achilles Therapeutics, is a biopharmaceutical company engages in developing transformative precision T-cell therapies to treat multiple types of solid tumors. It focuses on researching, developing and commercializing potentially novel cancer immunotherapies targeting clonal neoantigens.
CEO
Iraj Ali
Employees
159
Headquarters
London, Greater London
Founded
2020
ACHL Key Statistics
Market Cap
642.66M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
51.94K
High Today
$16.00
Low Today
$13.62
Open Price
$14.76
Volume
16.13K
52 Week High
$18.95
52 Week Low
$12.63
Analyst Ratings
83%
of 6 ratings
Buy
83.3%
Hold
0%
Sell
16.7%
ACHL Earnings
Q1 FY21
Estimated
— per share
Actual
Expected May 18, Pre-Market